Chromocell Therapeutics Corp
AMEX:CHRO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chromocell Therapeutics Corp
AMEX:CHRO
|
US |
|
H
|
HansaeMK Co Ltd
KRX:069640
|
KR |
|
Bank Victoria International Tbk PT
IDX:BVIC
|
ID |
|
A
|
Anglo American Platinum Ltd
JSE:AMS
|
ZA |
|
V
|
Vinafreight JSC
VN:VNF
|
VN |
|
Solytech Enterprise Corp
TWSE:1471
|
TW |
|
K
|
Klaipedos Nafta AB
F:XIC
|
LT |
|
Golden Agri-Resources Ltd
SGX:E5H
|
SG |
|
YOUZU Interactive Co Ltd
SZSE:002174
|
CN |
|
Ozon Holdings PLC
MOEX:OZON
|
CY |
|
Yesco Holdings Co Ltd
KRX:015360
|
KR |
|
G
|
Grodno SA
WSE:GRN
|
PL |
|
H
|
Hua Eng Wire And Cable Co Ltd
TWSE:1608
|
TW |
|
S
|
Spectrum Pharmaceuticals Inc
F:NTR
|
US |
|
H
|
Hongchang International Co Ltd
OTC:HCIL
|
CN |
|
C
|
Cooper Metals Ltd
ASX:CPM
|
AU |
|
S
|
Symphony Life Bhd
KLSE:SYMLIFE
|
MY |
|
Leatt Corp
OTC:LEAT
|
ZA |
|
A
|
Ananti Inc
KOSDAQ:025980
|
KR |
|
OneWater Marine Inc
NASDAQ:ONEW
|
US |
|
Kingsoft Cloud Holdings Ltd
NASDAQ:KC
|
CN |
|
Indel B SpA
MIL:INDB
|
IT |
|
Jiangsu Rainbow Heavy Industries Co Ltd
SZSE:002483
|
CN |
|
Columbus A/S
CSE:COLUM
|
DK |
Cash Flow Statement
Cash Flow Statement
Chromocell Therapeutics Corp
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(7)
|
(9)
|
(10)
|
(8)
|
(7)
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
|
| Other Non-Cash Items |
(0)
|
0
|
0
|
0
|
1
|
1
|
1
|
4
|
5
|
5
|
2
|
2
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(1)
|
(1)
|
0
|
1
|
1
|
2
|
2
|
2
|
1
|
(0)
|
0
|
1
|
|
| Cash from Operating Activities |
(2)
N/A
|
(2)
+15%
|
(1)
+27%
|
(2)
-29%
|
(1)
+11%
|
(1)
+7%
|
(1)
+0%
|
(1)
+24%
|
(3)
-185%
|
(5)
-96%
|
(6)
-6%
|
(4)
+23%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
6
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
1
|
|
| Other |
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
2
N/A
|
2
-15%
|
1
-17%
|
2
+17%
|
1
-11%
|
1
-5%
|
1
-17%
|
1
-10%
|
7
+538%
|
7
+3%
|
6
-7%
|
1
-87%
|
|
| Change in Cash | |||||||||||||
| Net Change in Cash |
0
N/A
|
0
N/A
|
0
+7 117%
|
0
-68%
|
0
-12%
|
0
+64%
|
(0)
N/A
|
0
N/A
|
4
+8 911%
|
1
-67%
|
0
-66%
|
(4)
N/A
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
(2)
N/A
|
(2)
+15%
|
(1)
+27%
|
(2)
-29%
|
(1)
+11%
|
(1)
+7%
|
(1)
+0%
|
(1)
+24%
|
(3)
-185%
|
(5)
-96%
|
(6)
-6%
|
(4)
+23%
|
|